Planned dose-escalating study to investigate the tolerability of a wide range of doses of BLX 155 in patients with haemodialysis graft thrombosis.
Phase of Trial: Phase I
Latest Information Update: 02 Aug 2007
At a glance
- Drugs BLX 155 (Primary)
- Indications Thrombosis
- Focus Adverse reactions
- 02 Aug 2007 New trial record.